| Issue Date | Title | Author(s) |
| 2018-01-01 | An interdimensional correlation framework for real-time estimation of six degree of freedom target motion using a single x-ray imager during radiotherapy | Nguyen, DT; Bertholet, J; Kim, JH; O'Brien, R; Booth, JT; Poulsen, PR; Keall, PJ |
| 2021-09 | Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights. | Shokoohian, B; Negahdari, B; Aboulkheyr Es, H; Abedi-Valugerdi, M; Baghaei, K; Agarwal, T; Maiti, TK; Hassan, M; Najimi, M; Vosough, M |
| 2021-05-03 | Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring | Lee, YYD; Nguyen, DT; Moodie, T; O’Brien, R; McMaster, A; Hickey, A; Pritchard, N; Poulsen, P; Tabaksblat, EM; Weber, B; Worm, E; Pryor, D; Chu, J; Hardcastle, N; Booth, J; Gebski, V; Wang, T; Keall, P |
| 2022-06-01 | Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases | Khin, NY; DeSilva, M; Clarke, S; Pavlakis, N; Rogan, CM; Ho-Shon, K; Lane, RJ |
| 2019-05-21 | A six-degree-of-freedom robotic motion system for quality assurance of real-time image-guided radiotherapy | Alnaghy, S; Kyme, A; Caillet, V; Nguyen, DT; O'Brien, R; Booth, JT; Keall, PJ |
| 2022-12-07 | HNF4α is possibly the missing link between epithelial–mesenchymal transition and Warburg effect during hepatocarcinogenesis | Shokouhian, B; Negahdari, B; Heydari, Z; Totonchi, M; Es, HA; Piryaei, A; Mostafavi, E; Vosough, M |
| 2022-08-29 | Hepatogenesis and hepatocarcinogenesis: Alignment of the main signaling pathways | Shokouhian, B; Es, HA; Negahdari, B; Tamimi, A; Shahdoust, M; Shpichka, A; Timashev, P; Hassan, M; Vosough, M |
| 2023-01 | Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma. | Pourhamzeh, M; Asadian, S; Mirzaei, H; Minaei, A; Shahriari, E; Shpichka, A; Es, HA; Timashev, P; Hassan, M; Vosough, M |
| 2023-06 | Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years. | Farina, E; Loglio, A; Tosetti, G; Degasperi, E; Viganò, M; Gentile, C; Monico, S; Perbellini, R; Borghi, M; Facchetti, F; Uceda Renteria, SC; Ceriotti, F; Cerini, F; Primignani, M; Lampertico, P |
